Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Help & FAQ
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press / Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?
John Burnett
,
Gerald Watts
Graduate Research School
Research output
:
Contribution to journal
›
Review article
59
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Dyslipidemias
62%
Familial Combined Hyperlipidemia
25%
Anticholesteremic Agents
23%
Hyperlipoproteinemia Type II
19%
Apolipoproteins B
17%
Fatty Liver
17%
Combination Drug Therapy
16%
Hypercholesterolemia
15%
Metabolic Syndrome
14%
Coronary Disease
14%
Liver Diseases
13%
Coronary Artery Disease
13%
Type 2 Diabetes Mellitus
12%
Cardiovascular Diseases
11%
Lipids
10%
Therapeutics
10%
Guidelines
10%
Drug Therapy
9%
Safety
9%
Liver
8%
Chemical Compounds
Triglyceride
67%
Sequestering Agent
31%
Protein
26%
Time
22%
Cholesterol
19%
Safety
18%
Metabolic
17%
Lipid
14%
Drug
11%